MedPath

Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality

Not Applicable
Recruiting
Conditions
Prostate Cancer
Registration Number
NCT03572621
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Prostate cancer is the most common cancer in France (54,000 cases in 2011). About 20,000 radical prostatectomies (PR) per year are performed. Despite the progress of PR over the past 20 years, the rate of erectile dysfunction post PR varies between 30 and 90% and only 16% of operated men recover their pre-treatment erections.

There is currently no validated post-prostatectomy rehabilitation protocol. The associations of patients, including the National Association of Prostate Cancer Patients have a very strong demand for treatment of sexual problems after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
240
Inclusion Criteria

Patients treated in urology consultation at the University Hospital of Lyon Sud or Edouard Herriot:

  • Aged over 18
  • presenting a cancerous pathology of the prostate having an indication of radical prostatectomy with or without preservation of the neurovascular strips.
  • affiliated to a social security scheme.
  • and having been informed and given informed consent to participation in the program.
Exclusion Criteria
  • Refusal of participation, signature of consent,
  • protected major patients, under guardianship or curators.
  • Patients unable to understand the course of the study
  • Patient with a documented history of cognitive or psychiatric disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change the quality of sexual life of patients treated with radical prostatectomy (PR)18 months

Comparison of the difference in self-Esteem quotation and Relationship (SEAR) questionnaire, between the experimental group and control, between inclusion and Month 18.

Secondary Outcome Measures
NameTimeMethod
Sexual functionMonth 1, 6, 12 and 18

Measure of The International Index of Erectile Function (IIEF-EF) score. This validated score measures the erectile component.

Penis size (cm)Month 1, 6, 12 and 18
Knowledge acquisition measured by quizz build for the study made of simulated casesMonth 1, 6, 12 and 18
Anxiety level measured by the Hospital Anxiety and Depression (HAD) scaleMonth 6 and18
Sexual quality of life of the partnerMonth 1, 6, 12 and 18

Index of Sexual Life (ISL) questionnaire, validated questionnaire specifically created to assess the impact of erectile dysfunction (ED) in the partner.

Depression level measured by the Hospital Anxiety and Depression (HAD) scaleMonth 6 and18
General quality of lifeMonth 1, 6, 12 and 18

Signing of questionnaire EuroQol-D5 (EQ-D5)

Number of erections obtained in the last monthMonth 1, 6, 12 and 18

Patient questionnaire to be filled every month at home by the patient and the partner

Erection Hardness Score (EHS)Month 1, 6, 12 and 18
Continence: urinary handicap measurement scale (MHU)Month 1, 6, 12 and 18
Number of intracavernous injections performed per weekMonth18

Patient questionnaire to be filled every month at home by the patient and the partner

acquisition of sexual intercourse management skills measured by quizz build for the study made of simulated casesMonth 1, 6, 12 and 18
Number of reports deemed satisfactoryMonth 1, 6, 12 and 18

Patient questionnaire to be filled every month at home by the patient and the partner

Patient Activation Measure (questionnaire PAM)Month18

Trial Locations

Locations (2)

Hôpital Hédouard Herriot

🇫🇷

Lyon, France

Centre Hospitalier Lyon Sud

🇫🇷

Pierre-Bénite, France

Hôpital Hédouard Herriot
🇫🇷Lyon, France
CUZIN Béatrice, MD
Contact
Béatrice CUZIN, MD
Principal Investigator
Marc COLOMBEL, MD
Sub Investigator
Lionel BADET, MD
Sub Investigator
Sébastien CROUZET, MD
Sub Investigator
Ricardo CODAS DUARTE, MD
Sub Investigator
Emilien SEIZILLES DE MAZANCOURT, MD
Sub Investigator
Xavier MATILLON, MD
Sub Investigator
Hakim FASSI-FEHRI, MD
Sub Investigator
Haixia YE, MD
Sub Investigator
Said OURFALI, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.